Cryosite Ltd (cte) Logo

Cryosite Ltd (CTE)

___:___ · AUD
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CTE Chart

CTE's Principal Activity is the provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) +192.15%
vs ASX 200 (1yr) +178.67%

Size

Market Capitalisation
ASX Rank 1,710 of 2,295
Sector Rank 155 of 177

Key Information

Shares Issued
Sector Healthcare
Similar Companies SCU / AMT / LSH
EPS $0.011
DPS $0.00
NTA per share $0.00

Broker Consensus

CTE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Company Overview

Cryosite Limited (CTE) is into provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples. Cryosite operates through Clinical Trials & Biological Storage and Logistics and Cord Blood and Tissues Storage.

Incorporation Details

Incorporated in NSW in December 1999.

Corporate Details

Head Office South Granville NSW 2142
Website www.cryosite.com
Registry Link Market Services
Auditor Mazars Risk & Assurance Pty Limited
Date Listed 9 May 2002

Upcoming Calendar (Forecasted)

Date Event
27/08/2021 Report (Prelim)
27/08/2021 Report (Annual)
24/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
14/03/2017 $0.005 0% $0.005 Interim 31/03/2017
07/09/2016 $0.005 0% $0.005 Final 04/10/2016
11/03/2016 $0.005 0% $0.005 Interim 31/03/2016
08/09/2015 $0.005 0% $0.005 Final 01/10/2015
13/03/2015 $0.005 0% $0.005 Interim 31/03/2015
08/09/2014 $0.01 0% $0.01 Final 24/09/2014
17/03/2014 $0.005 0% $0.005 Interim 04/04/2014
23/09/2013 $0.01 0% $0.01 Final 23/10/2013
18/03/2013 $0.005 0% $0.005 Interim 05/04/2013
28/09/2012 $0.005 0% $0.005 Final 23/10/2012
16/03/2012 $0.005 0% $0.005 Interim 05/04/2012

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio 0%
DRP No
DRP Features --

Directors & Management

Directors & Management

Name Title Since Bio
Mr John Hogg Chief Executive Officer Oct 2020
Mr Bryan Dulhunty Non-Executive Chairman,Non-Executive Director Jun 2019 Director Bio icon

Mr Bryan Dulhunty

Non-Executive Chairman,Non-Executive Director

Mr Dulhunty brings life science experience to the position having been involved in the industry for the past 20 years. Mr Dulhunty provides a range of consulting services to the life science industry. Mr Dulhunty has served as a director of a number of listed ASX and non-listed life science companies, including holding the positions of Executive Chairman and Managing Director of Viralytics Ltd from 2005 to 2012. He is also Chair of the Risk Committee.

Mrs Nicola Swift Non-Executive Director Nov 2016 Director Bio icon

Mrs Nicola Swift

Non-Executive Director

Mrs Swift has background in the international investment management and securities industry as a research director, portfolio manager and equity analyst. She has over 16 years of experience gained in London, Sydney and Boston with various global institutional investors. She is the CEO of Heads Over Heels Connections Pty Ltd and is also a Director of Ascham Foundation Ltd and Ascham School Ltd.

Mr Andrew John Kroger Non-Executive Director Nov 2011 Director Bio icon

Mr Andrew John Kroger

Non-Executive Director

Mr Kroger has had a career in stockbroking, law and general management including two years running Forsayth Group in 1990 which was Australia's ninth largest gold producer at that time. Mr Kroger is the owner of Process Wastewater Technologies LLC, a company with its major business being in wastewater in the United States.

Director Transactions

CTE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/06/21 Andrew Kroger Buy +83,133 $0.43 $35,747 On-market trade
08/06/21 Andrew Kroger Buy +473,325 $0.36 $170,209 On-market trade
01/06/21 Andrew Kroger Buy +820,894 $0.36 $295,521 On-market trade
17/04/20 Andrew Kroger Buy +49,422 $0.08 $3,953 On-market trade
06/04/20 Andrew Kroger Buy +75,024 $0.074 $5,551 On-market trade
13/03/20 Andrew Kroger Buy +571,716 $0.07 $40,016 On-market trade
09/03/20 Andrew Kroger Buy +7,000 $0.07 $490 On-market trade
09/03/20 Andrew Kroger Buy +7,000 $0.07 $490 On-market trade
04/03/20 Andrew Kroger Buy +371,159 $0.067 $24,872 On-market trade
04/03/20 Andrew Kroger Transfer 713,590 $0.07 $49,951 Off-market transfer
04/03/20 Andrew Kroger Transfer 713,590 $0.07 $49,951 Off-market transfer
04/03/20 Andrew Kroger Buy +371,159 $0.067 $24,872 On-market trade
30/08/19 Andrew Kroger Buy +500,000 $0.057 $28,500 Off-market trade
04/07/19 Bryan Dulhunty Issued 1,300,000 $0.05 $65,000 Issue of options

Director Interests

The current holdings of CTE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Andrew Kroger 17/06/2021 1,501,798 18,765,166 N/A N/A
Bryan Dulhunty 30/06/2020 N/A 30,000 1,300,000 N/A
Nicola Swift N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Jul 17, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Andrew Kroger and related entities 18,889,612 40.31%
Cell care Australia Pty Ltd 9,129,995 19.48%
Bnp Paribas Nominees Pty Ltd 2,087,384 4.45%
Mr. Alistair David Strong 2,000,000 4.27%
Bell Potter Nominees Ltd 1,758,236 3.75%
Mrs. Jane Susan Milliken 1,302,917 2.78%
Mr. Stephen Roberts 967,662 2.07%
Sunnyit Pty Ltd 851,000 1.82%
H F A Administration Pty Limited 480,000 1.02%
CVF Australia Pty Ltd 459,085 0.98%
Paradyce Pty Ltd 379,000 0.81%
Mr. Gary Griffith Robins 325,000 0.69%
Castlereagh Equity Pty Ltd 300,000 0.64%
Wifam Investments Pty Ltd 300,000 0.64%
Integument Pty Ltd 262,013 0.56%
Wheen Finance Pty Limited 228,454 0.49%
Mr. Peter Howells 215,730 0.46%
MNJ Holdings 214,931 0.46%
Naron Nominees Pty Ltd 213,007 0.45%
Mantou Republic Pty Ltd 200,000 0.43%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
DMX Asset Management Limited 11/03/2021 2,770,973 5.91
Andrew John Kroger 17/06/2021 20,266,964 43.25
Cell Care Australia Pty Ltd 09/03/2021 6,913,807 14.75

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
17-06-21 Andrew John Kroger 83,133 43.07 43.25
03-06-21 Andrew John Kroger 473,325 42.06 43.07
01-06-21 Andrew John Kroger 820,894 40.31 42.06
11-03-21 DMX Asset Management Limited 2,770,973 -- 5.91

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
09-03-21 Cell Care Australia Pty Ltd 546,193 15.9 14.8
05-03-21 Cell Care Australia Pty Ltd 712,607 17.4 15.9
23-02-21 Cell Care Australia Pty Ltd 522,393 18.6 17.4
16-02-21 Cell Care Australia Pty Ltd 534,995 19.7 18.6

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.13 30 June
2019 $0.05 28 June
2018 $0.09 29 June
2017 $0.16 28 June
2016 $0.21 28 June
2015 $0.35 30 June
2014 $0.36 30 June
Page Icon
CTE Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.